Sarepta Therapeutics Inc. (SRPT)
Sarepta Therapeutics Max Pain By Strike
SRPT trades at $20.58, 8.3% above the near-term max pain of $19 expiring Aug 22, 2025 (1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($10-$22.5), reflecting growing call interest at higher strikes. Key magnetic zone at 18 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Sarepta Therapeutics Max Pain By Expiry
Max pain for SRPT shows an upward trend from 10 to 22.5, suggesting bullish positioning in longer-dated options. The 74% spread signals divergent expectations across timeframes. Most levels below 20.58 may cap rallies. Strong magnetic level at 18 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 22, 2025 | 19 | -1.58 (-7.68%) |
| Aug 29, 2025 | 17 | -3.58 (-17.40%) |
| Sep 5, 2025 | 17.5 | -3.08 (-14.97%) |
| Sep 12, 2025 | 15 | -5.58 (-27.11%) |
| Sep 19, 2025 | 17.5 | -3.08 (-14.97%) |
| Sep 26, 2025 | 16.5 | -4.08 (-19.83%) |
| Oct 17, 2025 | 17.5 | -3.08 (-14.97%) |
| Nov 21, 2025 | 20 | -0.58 (-2.82%) |
| Jan 16, 2026 | 22.5 | 1.92 (9.33%) |
| Feb 20, 2026 | 15 | -5.58 (-27.11%) |
| Jun 18, 2026 | 17.5 | -3.08 (-14.97%) |
| Jan 15, 2027 | 15 | -5.58 (-27.11%) |
| Dec 17, 2027 | 10 | -10.58 (-51.41%) |